Wolters Kluwer unit to get new CEO

Share this article:
Wolters Kluwer Pharma Solutions will get a new CEO following the retirement of the pharmacy data and analytics firm's former head honcho, Mark Spiers, in April.
As interim CEO, the company named Robert Becker, who currently heads up sister company Wolters Kluwer Health. Becker will run both units until a permanent replacement for Spiers is found, said a source.
Becker has been CEO of Wolters Kluwer's Health division since 2008, after a five-year stint with the parent company that included running a unit of the Dutch conglomerate's Tax, Accounting & Legal division.
Spiers is joining the board of directors of Qforma, which provides advanced analytics and predictive modeling technologies for the health sciences industry, Qforma said in an announcement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?